Position in CTMX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,619,192
-$3,408,701 QoQ
Shares Held
3,365,118
-1.3% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#19
of 178 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Derivatives in CTMX
reported options exposure · as of Dec 31, 2025CallValue
$426,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,452,202 across 192 Biotechnology names. CTMX ranks #36 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in CTMX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,619,192 | 3,365,118 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,027,893 | 3,410,190 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $17,818,595 | 4,182,769 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $426,000 | 100,000 | Call | Sole | 2026-02-18 | |
| 2025-09-30 | $12,904,870 | 4,045,414 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,994,809 | 3,081,414 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,914 | 47,036 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $149,387 | 145,036 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,066,671 | 903,959 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $698,047 | 572,170 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $337,900 | 155,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||